TOPIC
Investigating the therapeutic approaches in immune-mediated inflammatory skin diseases.
VISION
Improved quality of life of people with immune-mediated inflammatory skin diseases.
MISSION
Assessing and addressing the risks associated with JAK inhibitors in immune-mediated inflammatory skin diseases.
PROJECT TITLE 1
Investigating the cardiovascular and venous thromboembolic risk with JAK inhibitors in immune-mediated inflammatory skin diseases: Systematic Review and Meta-analysis.
PROJECT TITLE 2
Investigating the risk of inflammatory bowel disease in patients treated with IL-17 inhibitors: Systematic Review and Meta-analysis.